ohsay,
The software mines constantly and at will, no need to “input”data.
There was no update after the presentation. The most recent updates occurred as a result of: the stops of the 2 “-stat” drugs from 2 different big pharmas, as well as the announcement of 2 execs resigning from lucrative jobs at BP to “land” somewhere else in late August. (These are hidden correlations. Nothing will or should be screamingly obvious - not unusual at all.) Also, the shelf was a positive movement.
The “movements” had no profound movement at all. (Sorry)
Standing now at 91% AD.
PDD is at 88% (in wake of some gut correlation on that front as well as the fact that trials have gone this far. Longer seems to indicate more likely.)
Rett is at ~60% (early stage trial)
Btw, last big moves were after our MOA was published in Cells Journal and the enrollment updates plus time.
Thanks for inquiring - will try to keep on it. (Was under the weather during some of this time and didn’t have the opportunity to update.)
Tick talk...
Bio